
|Articles|November 1, 2004
Self-report data overestimate use of PSA testing
Ann Arbor, MI-The use of PSA testing by urologists and primary care physicians is much lower than that suggested by practitioner- and patient-based published self-report estimates, according to a study of national clinic-report data conducted by urologists at the University of Michigan, Ann Arbor.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











